Back to
Deutsche Bank AG
CLYM
Showing 5 of 9 quarters
Position history for
Deutsche Bank AG's holdings in Climb Bio, Inc.
Yes. Deutsche Bank holds 34,673 shares of CLYM (Climb Bio), worth $452,136, as of its Q2 2026 13F filing. It increased the position from 1 shares in Q1 2026. Deutsche Bank has held CLYM since Q2 2025, across 5 quarterly 13F filings.
Current Value
$452,136
Current Shares
34,673
Total Value Change
+$436,782
Total Shares Change
+22,291
Quarter-by-Quarter History